Professor Dr Michael Klentze
Michael Klentze, Ph.D. is International Medical Director for
Thanyapura Health; President of Klentze Medical Education;
Associate Professor at the University of Udayana, Indonesia;
Associate Professor at UCSI Education Group, Malaysia;
Founder of the Klentze Medical Institute, Thailand; Honorary
President of the European Society of Anti-Aging Medicine (ESAAM); and
General Secretary of the
European Center of Aging Research and Education (ECARE).
As a worldwide recognized researcher in the field of clinical use of
polymorphisms, he lectures worldwide and gives seminars on
preventive medicine, endocrinology, and metabolic disorders.
Michael is the author of more than 100 papers, published in peer
reviewed publications and is the author and coauthor of 10 books
in the field of Anti-Aging Medicine, translated into several languages.
He authored
Anti-Aging. Die Macht der eigenen Hormone and
coauthored
Die revolutionäre Snips-Methode: Genetisch bedingte
Gesundheitsrisiken erkennen und aktiv gegensteuern.
In research together with the Genosense company of Vienna / Austria, Michael
developed several modules of polymorphisms used for the risk prediction
in preventive medicine. He later was
involved in stem cell research (reprogramming stem
cells) and clinical use of embryonic stem cells. Later he
cooperated with Dr. Vijay Sharma of Stempeutics Corp., Bangalore, India
in the field of clinical use of MSC stem cells.
Michael earned his degree in Medicine at Ludwig-Maximilians-University Munich
in 1975.
He completed his OB/GYN training at the
University of Tübingen and the Medical Association of South Wurtemberg
in 1982.
He completed his doctorate “cum laude” at Tbingen Urological Clinic
on the subject of “Urethral Syndrome” in 1984.
He completed his Psychotherapy and Psychoanalysis
training at the University of Tübingen in 1996.
He became a board certified physician in
Regenerative Medicine, Antiaging Medicine, and Endocrinology of Aging
at the American Academy of Anti Aging and Regenerative Medicine in 2001.
Read his
LinkedIn profile.